SearcharxivSearch

arXiv subjects

A. Vivanco-Lira

Publications and source records attributed to A. Vivanco-Lira.

2 recordsLinked to original sources

Stochastic and nonstochastic descriptions of the 2019-2020 measles outbreak worldwide with an emphasis in Mexico

Measles is an infectious disease caused by the Morbilivirus Measles Virus which has accompanied the human race since the 4th millennium BC, it is a disease usually concerning the paediatric population and in the past, before the advent of vaccination, almost all the population suffered from it, and in some cases the complications derived from this disease, such as central nervous involvement. Vaccination changed the course of the disease worldwide and diminished the associated comorbidities and mortality; in Mexico the vaccination program commenced in the decade of the 1970s and was successful in preventing peaks of infection. Nevertheless, due to various factors, has the world seen measles outbreaks once more, this commencing in the year 2019 and extending towards the year 2020. Here we make account of the biology and the pathophysiology of the viral infection, and present three models: one concerning the dynamics of the cases by means of a continuous method and a discrete stochastic model; one concerning the cellular compartmentalization behaviour of the virus, that is the viral tropism towards certain cell types in the host and the tendencies in extended or complicated infection; the last one concerning geographic behaviour of the virus, regarding in particular the tendencies in Mexico City, those involved at a global scale, and finally a model providing a prediction of the viral genotypes' distribution worldwide.

q-bio.PE

Novel therapeutic targets in chronic myeloid leukaemia through a discrete time discrete Markov chain model of BCR-ABL1 interactions

Chronic Myeloid Leukaemia (CML) is a blood-derived proliferative disorder, which is highly associated to a translocation of chromosomes 9 and 22 or the creation of Philadelphia chromosome Ph(+) cases, inducing the synthesis of a chimeric fusion protein, namely BCR-ABL1 (Breakpoint Cluster Region-Abelson 1 chimeric protein), which is known for driving the pathophysiology of the disease, however variants of CML are also recognized as CML Ph(-), these nonetheless account for a small percentage of the overall CML patients; posing thus the question whether BCR-ABL1 fusion protein is required for the whole of the pathophysiology of CML. Hereof, through a stochastic description, a discrete time discrete Markov chain depicts the various protein-protein interactions of BCR-ABL1 to better understand signalling pathways and time-dependent evolution of these pathways, as well as to provide prospective therapeutic protein targets to improve both the specificity of the treatment and the life-expectancy of the patients.

q-bio.CB